Skip to main content
AkademIndex

Products

For developers

AkademBasesoonOpen API for the ecosystem
← Back to work

Works cited by this work

201 works

Work: Targeted Protein Degradation and Delivery Strategies in the Context of Neurological Disorders

  1. Polymeric Nanoparticles for Drug Delivery

    Maximilian A. Beach, Umeka Nayanathara, Yanting Gao +4

    Review article20247 citations
    ABI

  2. Engineering precision nanoparticles for drug delivery

    Michael J. Mitchell, Margaret M. Billingsley, Rebecca M. Haley +3

    Review article20205 citations
    ABI

  3. mTOR: a pharmacologic target for autophagy regulation

    Young Chul Kim, Kun‐Liang Guan

    Review article20154 citations
    ABI

  4. Extracellular vesicles as a next-generation drug delivery platform

    Inge K. Herrmann, Matthew J. A. Wood, Gregor Fuhrmann

    Review article20214 citations
    ABI

  5. Preparation of pegylated nano-liposomal formulation containing SN-38: In vitro characterization and in vivo biodistribution in mice

    Fatemeh Atyabi, Anahita Farkhondehfai, Farnaz Esmaeili +1

    Article20093 citations
    ABI

  6. Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease

    Evandro Fei Fang, Yujun Hou, Konstantinos Palikaras +17

    Article20193 citations
    ABI

  7. Cell-Penetrating Peptides (CPPs) as Therapeutic and Diagnostic Agents for Cancer

    Ryan A. Bottens, Tohru Yamada

    Review article20223 citations
    ABI

  8. Small molecules in targeted cancer therapy: advances, challenges, and future perspectives

    Lei Zhong, Yueshan Li, Liang Xiong +8

    Review article20213 citations
    ABI

  9. Targeted protein degradation via the autophagy-lysosome system: AUTOTAC (AUTOphagy-TArgeting Chimera)

    Chang Hoon Ji, Min Ju Lee, Hee Yeon Kim +5

    Other20223 citations
    ABI

  10. Targeted Protein Degradation in Cancer: PROTACs, New Targets, and Clinical Mechanisms

    Bushra Faryal, Zain Ul Abideen, Muhammad Irfan +4

    ArticleProtein Degradation and InhibitorsBiomolecules20262 citations
    ABI

  11. Advances of Stimuli-Responsive Amphiphilic Copolymer Micelles in Tumor Therapy

    Yao Wang, Meng Lin, Tianfei Fan +3

    Review article20242 citations
    ABI

  12. Supramolecular artificial Nano-AUTACs enable tumor-specific metabolism protein degradation for synergistic immunotherapy

    Yazhen Wang, Lianyi Yang, C. Yan +8

    Article20242 citations
    ABI

  13. ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner

    Huai-Xiang Hao, Yang Xie, Yue Zhang +16

    Article20122 citations
    ABI

  14. Advanced drug delivery systems: Nanotechnology of health design A review

    Javad Safari, Zohre Zarnegar

    Review article20132 citations
    ABI

  15. Recent Progress in Bioconjugation Strategies for Liposome-Mediated Drug Delivery

    Bethany Almeida, Okhil K. Nag, Katherine E. Rogers +1

    Review article20202 citations
    ABI

  16. Protac-Induced Protein Degradation in Drug Discovery: Breaking the Rules or Just Making New Ones?

    Ian Churcher

    Review article20172 citations
    ABI

  17. AUTACs: Cargo-Specific Degraders Using Selective Autophagy

    Daiki Takahashi, Jun Moriyama, Tomoe Y. Nakamura +6

    Article20192 citations
    ABI

  18. Targeting estrogen receptor α for degradation with PROTACs: A promising approach to overcome endocrine resistance

    Xin Lin, Hua Xiang, Guoshun Luo

    Review article20202 citations
    ABI

  19. Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1

    Adam D. Cotton, Duy Nguyen, Josef A. Gramespacher +2

    Article20212 citations
    ABI

  20. Covalently Engineered Nanobody Chimeras for Targeted Membrane Protein Degradation

    Heng Zhang, Yu Han, Yuanfan Yang +7

    Article20212 citations
    ABI

  21. PROTAC targeted protein degraders: the past is prologue

    Miklós Békés, David R. Langley, Craig M. Crews

    Review article20222 citations
    ABI

  22. Proteolysis-targeting chimeras (PROTACs) in cancer therapy

    Xinyi Li, Wenchen Pu, Qingquan Zheng +3

    Article20222 citations
    ABI

  23. Molecular Glues: Capable Protein-Binding Small Molecules That Can Change Protein–Protein Interactions and Interactomes for the Potential Treatment of Human Cancer and Neurodegenerative Diseases

    Fengzhi Li, Ieman Aljahdali, Xiang Ling

    Review article20222 citations
    ABI

  24. Targeted Protein Degradation via Lysosomes

    Rishi R. Paudel, Dong Lu, Sandipan Chowdhury +2

    Review article20222 citations
    ABI

  25. Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology

    Jihoon Lee, Ki Woon Sung, Eun-Jin Bae +12

    Article20232 citations
    ABI